These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 2736622)

  • 1. Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment.
    Williams RL; Risau W; Zerwes HG; Drexler H; Aguzzi A; Wagner EF
    Cell; 1989 Jun; 57(6):1053-63. PubMed ID: 2736622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretion of SPARC by endothelial cells transformed by polyoma middle T oncogene inhibits the growth of normal endothelial cells in vitro.
    Sage EH
    Biochem Cell Biol; 1992 Jul; 70(7):579-92. PubMed ID: 1449724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine endothelioma cell lines transformed by polyoma middle T oncogene as target for and producers of cytokines.
    Bussolino F; De Rossi M; Sica A; Colotta F; Wang JM; Bocchietto E; Padura IM; Bosia A; DeJana E; Mantovani A
    J Immunol; 1991 Oct; 147(7):2122-9. PubMed ID: 1918946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial cell migration and invasiveness are induced by a soluble factor produced by murine endothelioma cells transformed by polyoma virus middle T oncogene.
    Taraboletti G; Belotti D; Dejana E; Mantovani A; Giavazzi R
    Cancer Res; 1993 Aug; 53(16):3812-6. PubMed ID: 8393382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human endothelial cells expressing polyoma middle T induce tumors.
    Primo L; Roca C; Ferrandi C; Lanfrancone L; Bussolino F
    Oncogene; 2000 Jul; 19(32):3632-41. PubMed ID: 10951569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of an established endothelial cell line from transgenic mouse hemangiomas.
    Dubois NA; Kolpack LC; Wang R; Azizkhan RG; Bautch VL
    Exp Cell Res; 1991 Oct; 196(2):302-13. PubMed ID: 1893941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of transformed endothelial cells in the absence of VEGFR-2/Flk-1 by Polyoma middle T oncogene.
    Mühlner U; Möhle-Steinlein U; Wizigmann-Voos S; Christofori G; Risau W; Wagner EF
    Oncogene; 1999 Jul; 18(29):4200-10. PubMed ID: 10435633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases.
    Taraboletti G; Garofalo A; Belotti D; Drudis T; Borsotti P; Scanziani E; Brown PD; Giavazzi R
    J Natl Cancer Inst; 1995 Feb; 87(4):293-8. PubMed ID: 7535861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial cell transformation by polyomavirus middle T antigen in mice lacking Src-related kinases.
    Kiefer F; Anhauser I; Soriano P; Aguzzi A; Courtneidge SA; Wagner EF
    Curr Biol; 1994 Feb; 4(2):100-9. PubMed ID: 7953508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RCAS/SCL-TVA animal model allows targeted delivery of polyoma middle T oncogene to vascular endothelial progenitors in vivo and results in hemangioma development.
    Sausville J; Molinolo AA; Cheng X; Frampton J; Takebe N; Gutkind JS; Feldman RA
    Clin Cancer Res; 2008 Jun; 14(12):3948-55. PubMed ID: 18559617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene.
    Montesano R; Pepper MS; Möhle-Steinlein U; Risau W; Wagner EF; Orci L
    Cell; 1990 Aug; 62(3):435-45. PubMed ID: 2379237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice transgenic with SV40-late-promoter-driven Polyomavirus Middle T oncogene exclusively develop hemangiomas.
    Xu Q; Chen W; Wang Z; Zheng J; Zhang Z
    Transgenic Res; 2009 Jun; 18(3):399-406. PubMed ID: 19067215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene.
    Williams RL; Courtneidge SA; Wagner EF
    Cell; 1988 Jan; 52(1):121-31. PubMed ID: 3345558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenes in the study of endothelial cell growth and differentiation.
    Wagner EF; Risau W
    Semin Cancer Biol; 1994 Apr; 5(2):137-45. PubMed ID: 7520302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Middle T antigen-transformed endothelial cells exhibit an increased activity of nitric oxide synthase.
    Ghigo D; Arese M; Todde R; Vecchi A; Silvagno F; Costamagna C; Dong QG; Alessio M; Heller R; Soldi R; Trucco F; Garbarino G; Pescarmona G; Mantovani A; Bussolino F; Bosia A
    J Exp Med; 1995 Jan; 181(1):9-19. PubMed ID: 7528781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hemangioendothelioma-derived cell line: its use as a model for the study of endothelial cell biology.
    Obeso J; Weber J; Auerbach R
    Lab Invest; 1990 Aug; 63(2):259-69. PubMed ID: 2166185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyoma virus middle-T-transformed PECAM-1 deficient mouse brain endothelial cells proliferate rapidly in culture and form hemangiomas in mice.
    Rothermel TA; Engelhardt B; Sheibani N
    J Cell Physiol; 2005 Jan; 202(1):230-9. PubMed ID: 15389523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of fibroblast growth factor-2-induced vascular tumor formation by the acyclic nucleoside phosphonate cidofovir.
    Liekens S; Neyts J; De Clercq E; Verbeken E; Ribatti D; Presta M
    Cancer Res; 2001 Jul; 61(13):5057-64. PubMed ID: 11431341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of growth factors, angiogenic enzymes and apoptosis in neovascularization and tumor growth-collected publications.
    Liekens S
    Verh K Acad Geneeskd Belg; 2002; 64(3):197-224. PubMed ID: 12238243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen: implications for the pathogenesis of opportunistic vascular tumors.
    Garlanda C; Parravicini C; Sironi M; De Rossi M; Wainstok de Calmanovici R; Carozzi F; Bussolino F; Colotta F; Mantovani A; Vecchi A
    Proc Natl Acad Sci U S A; 1994 Jul; 91(15):7291-5. PubMed ID: 8041783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.